Colombia Virtual Clinical Trials Market Size & Outlook

The virtual clinical trials market in Colombia is expected to reach a projected revenue of US$ 46.3 million by 2030. A compound annual growth rate of 5.8% is expected of Colombia virtual clinical trials market from 2024 to 2030.
Revenue, 2023 (US$M)
$31.2
Forecast, 2030 (US$M)
$46.3
CAGR, 2024 - 2030
5.8%
Report Coverage
Colombia

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Colombia virtual clinical trials market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Colombia virtual clinical trials market highlights

  • The Colombia virtual clinical trials market generated a revenue of USD 31.2 million in 2023 and is expected to reach USD 46.3 million by 2030.
  • The Colombia market is expected to grow at a CAGR of 5.8% from 2024 to 2030.
  • In terms of segment, interventional was the largest revenue generating study design in 2023.
  • Expanded Access is the most lucrative study design segment registering the fastest growth during the forecast period.


Virtual clinical trials market data book summary

Market revenue in 2023USD 31.2 million
Market revenue in 2030USD 46.3 million
Growth rate5.8% (CAGR from 2024 to 2030)
Largest segmentInterventional
Fastest growing segmentExpanded Access
Historical data2017 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationInterventional, Observational, Expanded Access
Key market players worldwideIcon PLC, PAREXEL, IQVIA Holdings Inc, Labcorp Holdings Inc, LEO Pharma, Medidata, Oracle Corp, Signant Health


Other key industry trends

  • In terms of revenue, Colombia accounted for 0.4% of the global virtual clinical trials market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Latin America, Brazil virtual clinical trials market is projected to lead the regional market in terms of revenue in 2030.
  • Argentina is the fastest growing regional market in Latin America and is projected to reach USD 142.8 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Virtual Clinical Trials Market Companies

Name Profile # Employees HQ Website
Signant Health View profile 1001-5000 Blue Bell, Pennsylvania, United States, North America https://www.signanthealth.com/
Medidata View profile 1001-5000 New York, New York, United States, North America https://www.medidata.com
PAREXEL View profile 10001+ Waltham, Massachusetts, United States, North America http://www.parexel.com
IQVIA Holdings Inc View profile 87000 2400 Ellis Road, Durham, NC, United States, 27703 https://www.iqvia.com
LEO Pharma View profile 1001-5000 Parsippany, New Jersey, United States, North America http://www.leo-pharma.us/
Icon PLC View profile 41150 South County Business Park, Leopardstown, Dublin, Ireland, D18 X5R3 https://www.iconplc.com
Labcorp Holdings Inc View profile 67000 358 South Main Street, Burlington, NC, United States, 27215 https://www.labcorp.com
Oracle Corp View profile 164000 2300 Oracle Way, Austin, TX, United States, 78741 https://www.oracle.com

Colombia virtual clinical trials market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to virtual clinical trials market will help companies and investors design strategic landscapes.


Interventional was the largest segment with a revenue share of 49.68% in 2023. Horizon Databook has segmented the Colombia virtual clinical trials market based on interventional, observational, expanded access covering the revenue growth of each sub-segment from 2018 to 2030.


Cancer is considered as one of the most prevalent diseases in Colombia. As per Cancer Country Profile Colombia Report, around 101,893 cases of cancer were reported in 2018. It is the second most common cause of morbidity in Colombian population. 

Cancer patients are at an increased risk of coronavirus disease. Hence, there is increasing demand for virtual clinical trials in the country. The repercussions of the ongoing COVID-19 pandemic led to the restriction of new and existing clinical trials in the country. 

As of 3rd February 2021, there are over 2,114,597 coronavirus cases and over 54,576 deaths have occurred due to the disease in Colombia. Virtual clinical trials have become a feasible option to complete pending clinical trials as well as initiate new trials.

Reasons to subscribe to Colombia virtual clinical trials market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Colombia virtual clinical trials market databook

  • Our clientele includes a mix of virtual clinical trials market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Colombia virtual clinical trials market , including forecasts for subscribers. This country databook contains high-level insights into Colombia virtual clinical trials market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Colombia virtual clinical trials market size, by study design, 2017-2030 (US$M)

Colombia Virtual Clinical Trials Market Outlook Share, 2023 & 2030 (US$M)

Colombia virtual clinical trials market size, by study design, 2017-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online